Disulfiram: Mechanisms, Applications, and Challenges

被引:58
作者
Lanz, Jenna [1 ]
Biniaz-Harris, Nicholas [1 ]
Kuvaldina, Mara [1 ]
Jain, Samta [2 ]
Lewis, Kim [2 ]
Fallon, Brian A. [1 ,3 ]
机构
[1] Columbia Univ, Vagelos Coll Phys & Surg, Lyme & Tick Borne Dis Res Ctr, Dept Psychiat,Irving Med Ctr, New York, NY 10032 USA
[2] Northeastern Univ, Antimicrobial Discovery Ctr, Dept Biol, Boston, MA 02115 USA
[3] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
来源
ANTIBIOTICS-BASEL | 2023年 / 12卷 / 03期
关键词
disulfiram; Antabuse; drug repurposing; Lyme disease; risks; addiction; ACID METHYL-ESTER; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; S-METHYL-N; N-DIETHYLTHIOCARBAMOYL SULFOXIDE; STRUCTURAL-CHARACTERIZATION; ELIMINATION KINETICS; BORRELIA-BURGDORFERI; MIXED NANOPARTICLES; COCAINE DEPENDENCE; NICKEL DERMATITIS; ENZYME ADDUCT;
D O I
10.3390/antibiotics12030524
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Since disulfiram's discovery in the 1940s and its FDA approval for alcohol use disorder, other indications have been investigated. This review describes potential clinical applications, associated risks, and challenges. Methods: For this narrative review, a PubMed search was conducted for articles addressing in vivo studies of disulfiram with an emphasis on drug repurposing for the treatment of human diseases. The key search terms were "disulfiram" and "Antabuse". Animal studies and in vitro studies highlighting important mechanisms and safety issues were also included. Results: In total, 196 sources addressing our research focus spanning 1948-2022 were selected for inclusion. In addition to alcohol use disorder, emerging data support a potential role for disulfiram in the treatment of other addictions (e.g., cocaine), infections (e.g., bacteria such as Staphylococcus aureus and Borrelia burgdorferi, viruses, parasites), inflammatory conditions, neurological diseases, and cancers. The side effects range from minor to life-threatening, with lower doses conveying less risk. Caution in human use is needed due to the considerable inter-subject variability in disulfiram pharmacokinetics. Conclusions: While disulfiram has promise as a "repurposed" agent in human disease, its risk profile is of concern. Animal studies and well-controlled clinical trials are needed to assess its safety and efficacy for non-alcohol-related indications.
引用
收藏
页数:27
相关论文
共 198 条
[1]   Treatment of alcohol use disorders in patients with alcoholic liver disease [J].
Addolorato, Giovanni ;
Mirijello, Antonio ;
Barrio, Pablo ;
Gual, Antoni .
JOURNAL OF HEPATOLOGY, 2016, 65 (03) :618-630
[2]   Diffuse subendocardial ischemia secondary to disulfiram-alcohol ingestion [J].
Agarwal, Rakesh .
INDIAN JOURNAL OF PHARMACOLOGY, 2022, 54 (02) :146-147
[3]   SERUM-ALBUMIN AND THE METABOLISM OF DISULFIRAM [J].
AGARWAL, RP ;
PHILLIPS, M ;
MCPHERSON, RA ;
HENSLEY, P .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (19) :3341-3347
[4]   What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion? [J].
Albensi, Benedict C. .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019, 7
[5]  
Ali Hussein M., 2022, Proceedings of the Indian National Science Academy Part B Biological Sciences, V92, P281, DOI [10.1007/s40011-021-01338-8, 10.1007/s40011-021-01338-8, 10.1109/ISCV54655.2022.9806080]
[6]   The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance [J].
Almeida-Silva, Juliana ;
Menezes, Diego Silva ;
Pereira Fernandes, Juan Mateus ;
Almeida, Marcio Cerqueira ;
Vasco-dos-Santos, Deyvison Rhuan ;
Saraiva, Roberto Magalhaes ;
Vicosa, Alessandra Lifsitch ;
Chavez Perez, Sandra Aurora ;
Andrade, Sonia Gumes ;
Suarez-Fontes, Ana Marcia ;
Vannier-Santos, Marcos Andre .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
[7]   Evaluation of Disulfiram Drug Combinations and Identification of Other More Effective Combinations against Stationary PhaseBorrelia burgdorferi [J].
Alvarez-Manzo, Hector S. ;
Zhang, Yumin ;
Shi, Wanliang ;
Zhang, Ying .
ANTIBIOTICS-BASEL, 2020, 9 (09) :1-15
[8]  
[Anonymous], PUBCHEM DIS
[9]  
Anton RF, 2001, J CLIN PSYCHIAT, V62, P11
[10]   New drugs are not enough-drug repositioning in oncology: An update [J].
Armando, Romina Gabriela ;
Gomez, Diego Luis Mengual ;
Gomez, Daniel Eduardo .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 56 (03) :651-684